Noradrenaline (Norepinephrine)
Brand names: Noradrenaline acid tartrate (generic)
Noradrenaline (norepinephrine) is a potent intravenous vasopressor used as the first-line agent to restore blood pressure in septic and other vasodilatory shock states in critical care.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a predominantly alpha-1 adrenergic agonist causing intense peripheral vasoconstriction and a rise in systemic vascular resistance, with modest beta-1 activity providing some inotropic support, thereby raising mean arterial pressure.
Prescribing in practice
- Extravasation causes severe local vasoconstriction and tissue necrosis, so it should be given through a central venous catheter (or a closely monitored large peripheral line as a temporising measure) via an infusion pump.
- Excessive vasoconstriction can compromise perfusion of the limbs, gut and kidneys and cause reflex bradycardia, so titrate to a defined mean arterial pressure target.
- It must never be given as a bolus; abrupt rate changes cause swings in blood pressure, so adjust gradually against continuous arterial monitoring.
Monitoring
Monitor continuous invasive arterial blood pressure, heart rate, peripheral and end-organ perfusion and the infusion site for extravasation.
Counselling the patient
- This is a powerful blood-pressure-supporting drip used in intensive care, usually given through a central line.
- Staff watch the drip site carefully because leakage outside the vein can damage tissue.
- The dose is adjusted continuously to keep blood pressure at a safe target.
Evidence & guidelines
Noradrenaline is the recommended first-line vasopressor in septic shock under the Surviving Sepsis Campaign guidelines.
Reference: Surviving Sepsis Campaign 2021; SOAP II Trial (De Backer et al, NEJM 2010); 65-TRIAL (Lamontagne et al, NEJM 2020); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- C-Peptide to Glucose Ratio · Diabetes Classification
- International Staging System (ISS) for Multiple Myeloma · Multiple Myeloma
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- Revised ISS (R-ISS) for Multiple Myeloma · Haematological Malignancy
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014)
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC